6-oxa-2-Azaspiro[4.5]decane hydrochloride, 97.0%, 1g

2-{[4-(4-methoxyphenyl)-5-methyl-4h-1,2,4-triazol-3-yl]sulfanyl}acetic acid, 97%, 250mg

9-(Bromomethyl)nonadecane, 97%, 100g

2-bromo-4,6-dichloropyrimidine, 97%, 1g

9-Bromospiro[benzo[c]fluorene-7,9'-xanthene], 95%, 1g

Pyrazolo[1,5-a]pyrimidine-5,7(4H,6H)-dione, 95.0%, 1g

tert-butyl 2-(3-nitro-1H-pyrazol-1-yl)acetate, 95.0%, 2g

(4,4-Difluorocyclohexyl)methanamine, 50mg

(4-BROMOTHIAZOL-2-YL)METHANAMINE HCL, 95.0%, 1g

4-Fluoro-4'-(trans-4-pentylcyclohexyl)biphenyl>98.0%(GC)1g

1-(2-Fluorophenyl)propan-1-amine hydrochloride, 97%, 100mg

1-amino-3-methylbutan-2-one hydrochloride, 95.0%, 250mg

Ácido metanosulfónico, min 99,5%, para síntesis, 1L, envase de vidrio